Analyze Diet
Journal of reproduction and fertility1996; 107(2); 241-248; doi: 10.1530/jrf.0.1070241

Differential effect of trilostane on the progestin milieu in the pregnant mare.

Abstract: Trilostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase, was administered intravenously to pregnant mares (n = 3) between day 277 and day 282 of gestation to determine its effect on the progestin milieu. In addition, placental tissue from mares at mid-gestation (150-300 days) (n = 4) were exposed to either deuterium-labelled pregnenolone alone or deuterium-labelled pregnenolone and trilostane to examine the effect of trilostane on placental metabolism of pregnenolone. Blood samples were collected from indwelling jugular catheters at frequent intervals for 48 h after infusion. Both plasma samples and incubation media were quantitatively analysed, after solid phase extraction and steroid derivitization, for concentrations of eight different progestin metabolites using gas chromatography and mass spectrometry. Trilostane infusion differentially affected the progestin milieu in vivo without inducing abortion. Forty-five minutes after infusion, maternal plasma concentrations of pregnenolone, 5-pregnene-3 beta, 20 beta-diol, 5 alpha-pregnane-3 beta,20 beta-diol and 3 beta-hydroxy-5 alpha-pregnan-20-one increased (P < 0.05) and remained high for 37 h. Concentrations of 5 alpha-pregnane-3,20-dione, 20 alpha-hydroxy-5 alpha-pregnan-3-one and 5 alpha-pregnane-3 beta,20 alpha-diol decreased 15 min after infusion (P < 0.05), yet 1.5 h after infusion, concentrations had increased and remained high until 37 h after infusion. Trilostane inhibited the conversion of pregnenolone to progesterone in vitro (P < 0.001) while mediating an increase (P < 0.05) in concentrations of 5 alpha-pregnane-3,20-dione and 3 beta-hydroxy-5 alpha-pregnan-20-one. These observations demonstrate that the pregnant mare possesses unique steroid hormone metabolic activity and suggests that another steroid, perhaps 5 alpha-pregnane-3,20-dione and not progesterone, is the important steroid precursor for the other progestin metabolites found in circulating plasma.
Publication Date: 1996-07-01 PubMed ID: 8882291DOI: 10.1530/jrf.0.1070241Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article examines how trilostane, a steroid inhibitor, affects the progestin hormone environment in pregnant mares. The study concluded that trilostane does alter progestin metabolism without causing abortion, suggesting there’s a potential use of these findings in equine reproduction.

Objective

The researchers aimed to understand the role of trilostane, a drug that inhibits the enzyme 3 beta-hydroxysteroid dehydrogenase, on progestin hormones in pregnant mares. They wanted to test the effect of its infusion on progestin concentration in maternal plasma and its effect on placental metabolism.

Research Methodology

  • The team administered trilostane intravenously to three mares between day 277 and day 282 of gestation.
  • They also exposed placental tissue sampled from mares at the mid-gestation period (150-300 days) to two experimental treatments: administered deuterium-labelled pregnenolone alone or alongside trilostane.
  • They collected blood samples at regular intervals for 48 hours after infusion and analyzed both plasma samples and incubation media following derivation.

Key Results

  • They found that after 45 minutes of infusion, concentrations of some compounds (pregnenolone, 5-pregnene-3 beta, 20 beta-diol, 5 alpha-pregnane-3 beta,20 beta-diol and 3 beta-hydroxy-5 alpha-pregnan-20-one) increased and remained high for 37 hours.
  • The concentrations of other compounds (5 alpha-pregnane-3,20-dione, 20 alpha-hydroxy-5 alpha-pregnan-3-one, and 5 alpha-pregnane-3 beta,20 alpha-diol) initially decreased 15 minutes after infusion but increased 1.5 hours later and stayed ensured for the next 37 hours.
  • In vitro experiments demonstrated that trilostane inhibited the conversion of pregnenolone to progesterone but mediates an increase in other compounds’ concentrations.

Implications

The researchers concluded that pregnant mares have a unique metabolic activity concerning steroid hormones. The results suggest that a steroid other than progesterone, possibly 5 alpha-pregnane-3,20-dione, serves as the crucial steroid precursor for other progestin metabolites within circulating plasma. Trilostane, therefore, might play a role in manipulating equine reproductive hormone metabolism. These findings contribute to a better understanding of equine reproduction and potentially assist in enhancing fertility.

Cite This Article

APA
Schutzer WE, Kerby JL, Holtan DW. (1996). Differential effect of trilostane on the progestin milieu in the pregnant mare. J Reprod Fertil, 107(2), 241-248. https://doi.org/10.1530/jrf.0.1070241

Publication

ISSN: 0022-4251
NlmUniqueID: 0376367
Country: England
Language: English
Volume: 107
Issue: 2
Pages: 241-248

Researcher Affiliations

Schutzer, W E
  • Department of Animal Sciences, Oregon State University, Corvallis 97331, USA.
Kerby, J L
    Holtan, D W

      MeSH Terms

      • 3-Hydroxysteroid Dehydrogenases / antagonists & inhibitors
      • 5-alpha-Dihydroprogesterone
      • Animals
      • Dihydrotestosterone / analogs & derivatives
      • Dihydrotestosterone / pharmacology
      • Female
      • Horses / blood
      • Male
      • Placenta / drug effects
      • Placenta / metabolism
      • Pregnancy
      • Pregnancy, Animal / blood
      • Pregnanediones / metabolism
      • Pregnanolone / metabolism
      • Pregnenolone / analogs & derivatives
      • Pregnenolone / blood
      • Pregnenolone / metabolism
      • Progesterone / metabolism
      • Progestins / blood

      Citations

      This article has been cited 1 times.
      1. Binli F, İnan İ, Büyükbudak F, Gram A, Kaya D, Liman N, Aslan S, Fındık M, Ay SS. The Efficacy of a 3β-Hydroxysteroid Dehydrogenase Inhibitor for the Termination of Mid-Term Pregnancies in Dogs. Animals (Basel) 2022 Sep 19;12(18).
        doi: 10.3390/ani12182475pubmed: 36139334google scholar: lookup